Glow-in-the-Dark brain surgery: new hope for kids with tumors?

NCT ID NCT06907485

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a drug called Gleolan (5-ALA) can make brain tumors glow during surgery in children aged 2 to 18. The drug is already used in adults to help surgeons remove more tumor tissue. Twenty children with suspected gliomas will drink the drug before surgery, and doctors will check how well the tumor lights up. The main goal is to see if this approach is feasible and safe in kids.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Gleolan (aminolevulinic acid hydrochloride, also called 5-ALA)
What this could lead to
If it works, this could help surgeons remove more of a child's brain tumor during surgery by making the tumor glow, potentially improving outcomes.
What could go wrong
This is a small, early feasibility study with only 20 children, so results may not apply to all. The drug can cause sun sensitivity, requiring children to stay in dim light for 2 days after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MidWest Children's Brain Tumor Center, Advocate Children's Hospital Park Ridge

    Chicago, Illinois, 60068, United States

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, 15224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.